| Literature DB >> 31205099 |
Yan Luo1, Hong Wu1, Xing-Liang Zhang1, Xi-Ting Li1, Sarah Robbins Scott2, Jun-Fang Chen1, Zun-You Wu2.
Abstract
BACKGROUND: Youths are disproportionally affected by the human immunodeficiency virus (HIV) infection. We aimed to assess anti-retroviral therapy (ART) initiation and viral suppression rates among student and non-student youths in Hangzhou, China.Entities:
Mesh:
Substances:
Year: 2019 PMID: 31205099 PMCID: PMC6629328 DOI: 10.1097/CM9.0000000000000264
Source DB: PubMed Journal: Chin Med J (Engl) ISSN: 0366-6999 Impact factor: 2.628
Characteristics of newly diagnosed human immunodeficiency virus cases between students and non-students aged 15 to 24 years in Hangzhou, China, 2012 to 2016.
Figure 1The proportion of students, non-students, and all youths living with HIV in Hangzhou initiating anti-retroviral therapy at 30 days, 90 days, and 12 months after their HIV diagnosis 2012 to 2016. (A) The proportion of students, non-students, and all youths initiating anti-retroviral therapy at 30 days after their HIV diagnosis, 2012 to 2016. In 2012, less than 20% of students, non-students, and all youths initiated ART within 30 days of their HIV diagnosis. However, by 2016, these rates have increased to more than 60% amongst all groups. (B) The proportion of students, non-students, and all youths initiating anti-retroviral therapy at 90 days after their HIV diagnosis, 2012 to 2016. The proportion of students, non-students, and all youths initiating ART within 90 days of their HIV diagnosis has been increasing over time, to more than 80% in 2016. (C) The proportion of students, non-students, and all youths initiating anti-retroviral therapy within 12 months of their HIV diagnosis, 2012 to 2016. The proportion of students, non-students, and all youths initiating ART increased from less than 50% in 2012 to over 90% in 2015. However, the proportion dropped to a little less than 70% in 2016. ART: Anti-retroviral therapy; HIV: Human immunodeficiency virus.
Initiation of anti-retroviral therapy within 30 days, 90 days, and 12 months of human immunodeficiency virus diagnosis between student and non-student youths aged 15 to 24 years in Hangzhou, China, 2012 to 2016.
Figure 2The proportion of students, non-students, and all youths living with HIV in Hangzhou, China who achieved virological suppression at 12 months after their HIV diagnosis and at 12 months after initiation of anti-retroviral therapy, 2012 to 2016. (A) The proportion of students, non-students, and all youths living with HIV who achieved virological suppression at 12 months after their HIV diagnosis, 2012 to 2016. Overall, both students and non-students achieving virological suppression at 12 months after HIV diagnosis were all less than 20% in 2012 to 2016 except non-students reached 20.9% in 2015; (B) The proportion of students, non-students, and all youths living with HIV who achieved virological suppression at 12 months of initiating antiretroviral therapy, 2012 to 2016. The proportions of virological suppression were below 80% in students, non-students, and all youths in 2012 to 2016 except in 2014. HIV: Human immunodeficiency virus.
Viral load test and virological suppression at 12 months after human immunodeficiency virus diagnosis and viral load test and virological suppression at 12 months after initiating anti-retroviral therapy among student and non-students aged 15 to 24 years living with HIV in Hangzhou, China, 2012 to 2016.